PCN99 THE COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF RITUXIMAB(HANLIKANG) FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA

Saved in:

Bibliographic Details
Published in	Value in health Vol. 22; p. S455
Main Authors	Zhao, M.M., Xiang, Y., Juying, W., Jia, S.H., Chen, B.B., Fan, C.S.
Format	Journal Article
Language	English
Published	Elsevier Inc 01.11.2019
Online Access	Get full text

Loading…

More Information
ISSN:	1098-3015 1524-4733
DOI:	10.1016/j.jval.2019.09.296